Individualizing care for the many: The evolving role of professional continuous glucose monitoring systems in clinical practice

Diabetes Educator

Volumn 36, Issue SUPPL. 1, 2010, Pages

  Nardacci, Elizabeth A ^a   Bode, Bruce W ^b   Hirsch, Irl B ^c  

^a ALBANY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE OXIDASE;

AMBULATORY MONITORING; ARTICLE; BLOOD; BLOOD GLUCOSE MONITORING; ELECTRODE; EQUIPMENT DESIGN; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSTRUMENTATION; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSONALIZED MEDICINE; STANDARD;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTRODES; EQUIPMENT DESIGN; GLUCOSE OXIDASE; HOMEOSTASIS; HUMANS; INDIVIDUALIZED MEDICINE; MONITORING, AMBULATORY;

EID: 77953739569     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721710362798     Document Type: Article

References (20)

1. Centers for Disease Control. Self-monitoring of blood glucose among adults with diabetes-United States, 1997-2006. MMWR Weekly. 2007;56:1133-1137.
2. Hirsch IB Blood glucose monitoring technology: translating data into practice. Endocr Pract. 2004;10:67-76.
3. Hirsch IB, Armstrong D., Bergenstal RM,et al.Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring. Diabetes Technol Ther. 2008;10:232-244.
4. Gilliam LK, Hirsch IB Practical aspects of real-time continuous glucose monitoring. Diabetes Technol Ther. 2009;11:S75-S82.
5. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract. 1999;46:183-190.
6. Chetty VT, Almulla A., Odueyungbo A., Thabane L. The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1C (HBA1c) levels in type 1 diabetic patients: a systematic review. Diabetes Res Clin Pract. 2008;81:79-87.
7. Nathan DM, Cleary PA, Backlund JY,et al.Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643-2653.
8. Akalin S., Berntorp K., Ceriello A.,et al.Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control. Int J Clin Pract. 2009;63:1421-1425.
9. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-1589.
10. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med. 2009;169:1307-1316.
11. Brownlee M., Hirsch IB Glycemic variability: a hemoglobin A1C-independent risk factor for diabetic complications. JAMA. 2006;295:1707-1708.
12. Grant RW, Pirraglia PA, Meigs JB, Singer DE Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med. 2004;164:1134-1139.
13. Alexander GC, Sehgal NL, Maloney RM, Stafford RS National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med. 2008; 168:2088-2094.
14. Huang ES, Basu A., O'Grady M., Capretta JC Projecting the future diabetes population size and related costs for the U.S. Diabetes Care. 2009;32:2225-2229.
15. Tanenberg R., Bode B., Lane W.,et al.Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc. 2004;79:1521-1526.
16. Boland E., Monsod T., Delucia M., Brandt CA, Fernando S., Tamborlane WV Limitations of conventional methods of self-monitoring of blood glucose. Diabetes Care. 2001;24:1858-1862.
17. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33:S11-S61.
18. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13:1-68.
19. Heinemann L., Nosek L., Kapitza C., Schweitzer MA, Krinelke L. Changes in basal insulin infusion rates with subcutaneous insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetes. Diabetes Care. 2009;32:1437-1439.
20. Kinsley B. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus. Clin Ther. 2007;29: S153-S160.